SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-025542
Filing Date
2022-05-11
Accepted
2022-05-11 15:15:22
Documents
45
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_biomxinc.htm   iXBRL 10-Q 441472
2 CERTIFICATIONS f10q0322ex31-1_biomxinc.htm EX-31.1 9085
3 CERTIFICATIONS f10q0322ex31-2_biomxinc.htm EX-31.2 10451
4 CERTIFICATIONS f10q0322ex32_biomxinc.htm EX-32 7020
  Complete submission text file 0001213900-22-025542.txt   2796006

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE phge-20220331.xsd EX-101.SCH 32412
6 XBRL CALCULATION FILE phge-20220331_cal.xml EX-101.CAL 24372
7 XBRL DEFINITION FILE phge-20220331_def.xml EX-101.DEF 141162
8 XBRL LABEL FILE phge-20220331_lab.xml EX-101.LAB 291654
9 XBRL PRESENTATION FILE phge-20220331_pre.xml EX-101.PRE 150520
39 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_biomxinc_htm.xml XML 286564
Mailing Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 5TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Filer) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38762 | Film No.: 22913339
SIC: 2836 Biological Products, (No Diagnostic Substances)